Business

Neurim Pharmaceuticals markets its new drugs through strategic alliances with reputable marketing and distribution partners on whose marketing expertise we rely.

Neurim has so far established marketing and sales agreements with Teva, Takeda, Aspen Pharmacare, DKSH, Flynn, Medice, Italfarmaco, Biocodex, Kuhnil Pharm, Fidia, Juste and Biopas.
We are actively seeking additional strategic alliances.

Please feel free to contact us:

Dr. Hansjoerg Jakubetz
Director Corporate Business Development
Email: business@neurim.com

  • Text size: A A A
  • Circadin
  • Recent news

    • Neurim Pharmaceuticals Grants Exeltis Marketing Rights for Paediatric Prolonged-Release Melatonin (“PedPRM”) in Spain
    • Neurim Pharmaceuticals Paediatric Prolonged-Release Melatonin (“PedPRM”) to be Marketed by Biocodex in France
    • Neurim Pharmaceuticals Paediatric Prolonged-Release Melatonin (“PedPRM”) to be Marketed by Kuhnil Pharmaceutical in South Korea
  • Partners

    Partners